nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—head and neck cancer	0.533	1	CbGaD
Etoricoxib—CYP2D6—Hydroxyurea—head and neck cancer	0.0777	0.378	CbGbCtD
Etoricoxib—CYP1A2—Fluorouracil—head and neck cancer	0.036	0.175	CbGbCtD
Etoricoxib—CYP2C9—Fluorouracil—head and neck cancer	0.0325	0.158	CbGbCtD
Etoricoxib—CYP2D6—Vinblastine—head and neck cancer	0.0275	0.134	CbGbCtD
Etoricoxib—CYP3A4—Vinblastine—head and neck cancer	0.0175	0.0851	CbGbCtD
Etoricoxib—CYP3A4—Docetaxel—head and neck cancer	0.0144	0.0701	CbGbCtD
Etoricoxib—Angina unstable—Docetaxel—head and neck cancer	0.00252	0.0222	CcSEcCtD
Etoricoxib—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.00233	0.0206	CcSEcCtD
Etoricoxib—Platelet count decreased—Hydroxyurea—head and neck cancer	0.00206	0.0182	CcSEcCtD
Etoricoxib—Peptic ulcer—Vinblastine—head and neck cancer	0.00201	0.0177	CcSEcCtD
Etoricoxib—Breast cancer—Docetaxel—head and neck cancer	0.00174	0.0154	CcSEcCtD
Etoricoxib—Atrial flutter—Docetaxel—head and neck cancer	0.00167	0.0148	CcSEcCtD
Etoricoxib—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00159	0.014	CcSEcCtD
Etoricoxib—Skin ulcer—Hydroxyurea—head and neck cancer	0.00157	0.0139	CcSEcCtD
Etoricoxib—Cellulitis—Vinblastine—head and neck cancer	0.00148	0.013	CcSEcCtD
Etoricoxib—Heartburn—Fluorouracil—head and neck cancer	0.00128	0.0113	CcSEcCtD
Etoricoxib—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00125	0.011	CcSEcCtD
Etoricoxib—Neoplasm—Vinblastine—head and neck cancer	0.00121	0.0107	CcSEcCtD
Etoricoxib—Blood urea increased—Hydroxyurea—head and neck cancer	0.00116	0.0102	CcSEcCtD
Etoricoxib—Neoplasm—Hydroxyurea—head and neck cancer	0.00111	0.00978	CcSEcCtD
Etoricoxib—Celecoxib—PTGS2—head and neck cancer	0.0011	1	CrCbGaD
Etoricoxib—Haemorrhoids—Docetaxel—head and neck cancer	0.00108	0.00956	CcSEcCtD
Etoricoxib—Polyp—Docetaxel—head and neck cancer	0.00105	0.00924	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000995	0.00879	CcSEcCtD
Etoricoxib—Hepatic failure—Hydroxyurea—head and neck cancer	0.000989	0.00874	CcSEcCtD
Etoricoxib—Cellulitis—Fluorouracil—head and neck cancer	0.000969	0.00856	CcSEcCtD
Etoricoxib—Herpes simplex—Fluorouracil—head and neck cancer	0.000957	0.00845	CcSEcCtD
Etoricoxib—Cyst—Docetaxel—head and neck cancer	0.000952	0.00841	CcSEcCtD
Etoricoxib—Heartburn—Docetaxel—head and neck cancer	0.000925	0.00817	CcSEcCtD
Etoricoxib—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000833	0.00736	CcSEcCtD
Etoricoxib—Hepatotoxicity—Docetaxel—head and neck cancer	0.000824	0.00728	CcSEcCtD
Etoricoxib—Angina pectoris—Vinblastine—head and neck cancer	0.000821	0.00725	CcSEcCtD
Etoricoxib—Breast disorder—Hydroxyurea—head and neck cancer	0.000803	0.0071	CcSEcCtD
Etoricoxib—Pancreatitis—Hydroxyurea—head and neck cancer	0.000753	0.00665	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000741	0.00654	CcSEcCtD
Etoricoxib—Myocardial infarction—Vinblastine—head and neck cancer	0.000736	0.0065	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000736	0.0065	CcSEcCtD
Etoricoxib—Weight increased—Hydroxyurea—head and neck cancer	0.000699	0.00618	CcSEcCtD
Etoricoxib—Infestation—Hydroxyurea—head and neck cancer	0.000685	0.00605	CcSEcCtD
Etoricoxib—Infestation NOS—Hydroxyurea—head and neck cancer	0.000685	0.00605	CcSEcCtD
Etoricoxib—Haemoglobin—Vinblastine—head and neck cancer	0.000678	0.00599	CcSEcCtD
Etoricoxib—Haemorrhage—Vinblastine—head and neck cancer	0.000674	0.00596	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000672	0.00593	CcSEcCtD
Etoricoxib—Hypoaesthesia—Vinblastine—head and neck cancer	0.000671	0.00593	CcSEcCtD
Etoricoxib—Pharyngitis—Vinblastine—head and neck cancer	0.000669	0.00591	CcSEcCtD
Etoricoxib—Stomatitis—Hydroxyurea—head and neck cancer	0.000668	0.0059	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000648	0.00572	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00064	0.00565	CcSEcCtD
Etoricoxib—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000636	0.00562	CcSEcCtD
Etoricoxib—Blood pressure increased—Docetaxel—head and neck cancer	0.000636	0.00562	CcSEcCtD
Etoricoxib—Haemoglobin—Hydroxyurea—head and neck cancer	0.000618	0.00546	CcSEcCtD
Etoricoxib—Haemorrhage—Hydroxyurea—head and neck cancer	0.000615	0.00543	CcSEcCtD
Etoricoxib—Hallucination—Hydroxyurea—head and neck cancer	0.000612	0.00541	CcSEcCtD
Etoricoxib—Cardiac arrest—Fluorouracil—head and neck cancer	0.000609	0.00537	CcSEcCtD
Etoricoxib—Neuropathy—Docetaxel—head and neck cancer	0.000597	0.00528	CcSEcCtD
Etoricoxib—Alopecia—Vinblastine—head and neck cancer	0.000596	0.00526	CcSEcCtD
Etoricoxib—Neoplasm—Docetaxel—head and neck cancer	0.000575	0.00508	CcSEcCtD
Etoricoxib—Muscular weakness—Fluorouracil—head and neck cancer	0.000564	0.00499	CcSEcCtD
Etoricoxib—Angiopathy—Hydroxyurea—head and neck cancer	0.000558	0.00493	CcSEcCtD
Etoricoxib—Alopecia—Hydroxyurea—head and neck cancer	0.000544	0.0048	CcSEcCtD
Etoricoxib—Anaemia—Vinblastine—head and neck cancer	0.000543	0.00479	CcSEcCtD
Etoricoxib—Angina pectoris—Fluorouracil—head and neck cancer	0.000539	0.00476	CcSEcCtD
Etoricoxib—Erythema—Hydroxyurea—head and neck cancer	0.000535	0.00473	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000531	0.00469	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000514	0.00454	CcSEcCtD
Etoricoxib—Hepatic failure—Docetaxel—head and neck cancer	0.000514	0.00454	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000509	0.0045	CcSEcCtD
Etoricoxib—Hypertension—Vinblastine—head and neck cancer	0.000507	0.00448	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000505	0.00446	CcSEcCtD
Etoricoxib—Pneumonia—Fluorouracil—head and neck cancer	0.000496	0.00438	CcSEcCtD
Etoricoxib—Anaemia—Hydroxyurea—head and neck cancer	0.000495	0.00437	CcSEcCtD
Etoricoxib—Infestation NOS—Fluorouracil—head and neck cancer	0.000493	0.00436	CcSEcCtD
Etoricoxib—Infestation—Fluorouracil—head and neck cancer	0.000493	0.00436	CcSEcCtD
Etoricoxib—Visual disturbance—Docetaxel—head and neck cancer	0.000487	0.00431	CcSEcCtD
Etoricoxib—Atrial fibrillation—Docetaxel—head and neck cancer	0.000487	0.00431	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000486	0.00429	CcSEcCtD
Etoricoxib—Renal impairment—Docetaxel—head and neck cancer	0.000485	0.00429	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000483	0.00427	CcSEcCtD
Etoricoxib—Myocardial infarction—Fluorouracil—head and neck cancer	0.000483	0.00427	CcSEcCtD
Etoricoxib—Stomatitis—Fluorouracil—head and neck cancer	0.000481	0.00425	CcSEcCtD
Etoricoxib—Urinary tract infection—Fluorouracil—head and neck cancer	0.000479	0.00423	CcSEcCtD
Etoricoxib—Conjunctivitis—Fluorouracil—head and neck cancer	0.000479	0.00423	CcSEcCtD
Etoricoxib—Thrombocytopenia—Vinblastine—head and neck cancer	0.000469	0.00414	CcSEcCtD
Etoricoxib—Epistaxis—Fluorouracil—head and neck cancer	0.000465	0.00411	CcSEcCtD
Etoricoxib—Sinusitis—Fluorouracil—head and neck cancer	0.000463	0.00409	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000462	0.00408	CcSEcCtD
Etoricoxib—Pain in extremity—Docetaxel—head and neck cancer	0.000462	0.00408	CcSEcCtD
Etoricoxib—Anorexia—Vinblastine—head and neck cancer	0.000457	0.00403	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000453	0.004	CcSEcCtD
Etoricoxib—Haemoglobin—Fluorouracil—head and neck cancer	0.000445	0.00393	CcSEcCtD
Etoricoxib—Haemorrhage—Fluorouracil—head and neck cancer	0.000443	0.00391	CcSEcCtD
Etoricoxib—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00044	0.00389	CcSEcCtD
Etoricoxib—Pharyngitis—Fluorouracil—head and neck cancer	0.000439	0.00388	CcSEcCtD
Etoricoxib—Oedema—Hydroxyurea—head and neck cancer	0.000437	0.00386	CcSEcCtD
Etoricoxib—Infection—Hydroxyurea—head and neck cancer	0.000434	0.00383	CcSEcCtD
Etoricoxib—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000429	0.00379	CcSEcCtD
Etoricoxib—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000428	0.00378	CcSEcCtD
Etoricoxib—Skin disorder—Hydroxyurea—head and neck cancer	0.000424	0.00375	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000422	0.00373	CcSEcCtD
Etoricoxib—Breast disorder—Docetaxel—head and neck cancer	0.000417	0.00369	CcSEcCtD
Etoricoxib—Anorexia—Hydroxyurea—head and neck cancer	0.000417	0.00368	CcSEcCtD
Etoricoxib—Decreased appetite—Vinblastine—head and neck cancer	0.000417	0.00368	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000416	0.00367	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000416	0.00367	CcSEcCtD
Etoricoxib—Cramp muscle—Docetaxel—head and neck cancer	0.000416	0.00367	CcSEcCtD
Etoricoxib—Pain—Vinblastine—head and neck cancer	0.00041	0.00362	CcSEcCtD
Etoricoxib—Constipation—Vinblastine—head and neck cancer	0.00041	0.00362	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000407	0.0036	CcSEcCtD
Etoricoxib—Arrhythmia—Fluorouracil—head and neck cancer	0.000395	0.00349	CcSEcCtD
Etoricoxib—Feeling abnormal—Vinblastine—head and neck cancer	0.000395	0.00349	CcSEcCtD
Etoricoxib—Bronchospasm—Docetaxel—head and neck cancer	0.000393	0.00347	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000392	0.00346	CcSEcCtD
Etoricoxib—Alopecia—Fluorouracil—head and neck cancer	0.000391	0.00346	CcSEcCtD
Etoricoxib—Dyspnoea—Hydroxyurea—head and neck cancer	0.00039	0.00344	CcSEcCtD
Etoricoxib—Angina pectoris—Docetaxel—head and neck cancer	0.000389	0.00343	CcSEcCtD
Etoricoxib—Somnolence—Hydroxyurea—head and neck cancer	0.000388	0.00343	CcSEcCtD
Etoricoxib—Erythema—Fluorouracil—head and neck cancer	0.000385	0.0034	CcSEcCtD
Etoricoxib—Dyspepsia—Hydroxyurea—head and neck cancer	0.000385	0.0034	CcSEcCtD
Etoricoxib—Decreased appetite—Hydroxyurea—head and neck cancer	0.00038	0.00336	CcSEcCtD
Etoricoxib—Abdominal pain—Vinblastine—head and neck cancer	0.000379	0.00335	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000377	0.00333	CcSEcCtD
Etoricoxib—Fatigue—Hydroxyurea—head and neck cancer	0.000377	0.00333	CcSEcCtD
Etoricoxib—Pain—Hydroxyurea—head and neck cancer	0.000374	0.0033	CcSEcCtD
Etoricoxib—Constipation—Hydroxyurea—head and neck cancer	0.000374	0.0033	CcSEcCtD
Etoricoxib—Weight increased—Docetaxel—head and neck cancer	0.000363	0.00321	CcSEcCtD
Etoricoxib—Vision blurred—Fluorouracil—head and neck cancer	0.000363	0.00321	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00036	0.00318	CcSEcCtD
Etoricoxib—Pneumonia—Docetaxel—head and neck cancer	0.000358	0.00316	CcSEcCtD
Etoricoxib—Anaemia—Fluorouracil—head and neck cancer	0.000356	0.00315	CcSEcCtD
Etoricoxib—Infestation NOS—Docetaxel—head and neck cancer	0.000356	0.00314	CcSEcCtD
Etoricoxib—Infestation—Docetaxel—head and neck cancer	0.000356	0.00314	CcSEcCtD
Etoricoxib—Hypersensitivity—Vinblastine—head and neck cancer	0.000353	0.00312	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000353	0.00312	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000351	0.0031	CcSEcCtD
Etoricoxib—Renal failure—Docetaxel—head and neck cancer	0.00035	0.00309	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000349	0.00308	CcSEcCtD
Etoricoxib—Myocardial infarction—Docetaxel—head and neck cancer	0.000349	0.00308	CcSEcCtD
Etoricoxib—Stomatitis—Docetaxel—head and neck cancer	0.000347	0.00306	CcSEcCtD
Etoricoxib—Jaundice—Docetaxel—head and neck cancer	0.000347	0.00306	CcSEcCtD
Etoricoxib—Conjunctivitis—Docetaxel—head and neck cancer	0.000346	0.00306	CcSEcCtD
Etoricoxib—Asthenia—Vinblastine—head and neck cancer	0.000344	0.00304	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000337	0.00297	CcSEcCtD
Etoricoxib—Epistaxis—Docetaxel—head and neck cancer	0.000336	0.00297	CcSEcCtD
Etoricoxib—Chest pain—Fluorouracil—head and neck cancer	0.000328	0.0029	CcSEcCtD
Etoricoxib—Diarrhoea—Vinblastine—head and neck cancer	0.000328	0.0029	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000322	0.00284	CcSEcCtD
Etoricoxib—Haemoglobin—Docetaxel—head and neck cancer	0.000321	0.00284	CcSEcCtD
Etoricoxib—Haemorrhage—Docetaxel—head and neck cancer	0.00032	0.00282	CcSEcCtD
Etoricoxib—Hepatitis—Docetaxel—head and neck cancer	0.00032	0.00282	CcSEcCtD
Etoricoxib—Hypoaesthesia—Docetaxel—head and neck cancer	0.000318	0.00281	CcSEcCtD
Etoricoxib—Confusional state—Fluorouracil—head and neck cancer	0.000317	0.0028	CcSEcCtD
Etoricoxib—Pharyngitis—Docetaxel—head and neck cancer	0.000317	0.0028	CcSEcCtD
Etoricoxib—Dizziness—Vinblastine—head and neck cancer	0.000317	0.0028	CcSEcCtD
Etoricoxib—Urinary tract disorder—Docetaxel—head and neck cancer	0.000316	0.00279	CcSEcCtD
Etoricoxib—Oedema peripheral—Docetaxel—head and neck cancer	0.000315	0.00278	CcSEcCtD
Etoricoxib—Oedema—Fluorouracil—head and neck cancer	0.000315	0.00278	CcSEcCtD
Etoricoxib—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000315	0.00278	CcSEcCtD
Etoricoxib—Connective tissue disorder—Docetaxel—head and neck cancer	0.000314	0.00277	CcSEcCtD
Etoricoxib—Asthenia—Hydroxyurea—head and neck cancer	0.000314	0.00277	CcSEcCtD
Etoricoxib—Urethral disorder—Docetaxel—head and neck cancer	0.000313	0.00277	CcSEcCtD
Etoricoxib—Infection—Fluorouracil—head and neck cancer	0.000312	0.00276	CcSEcCtD
Etoricoxib—Nervous system disorder—Fluorouracil—head and neck cancer	0.000308	0.00272	CcSEcCtD
Etoricoxib—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000308	0.00272	CcSEcCtD
Etoricoxib—Visual impairment—Docetaxel—head and neck cancer	0.000308	0.00272	CcSEcCtD
Etoricoxib—Vomiting—Vinblastine—head and neck cancer	0.000305	0.00269	CcSEcCtD
Etoricoxib—Erythema multiforme—Docetaxel—head and neck cancer	0.000302	0.00267	CcSEcCtD
Etoricoxib—Headache—Vinblastine—head and neck cancer	0.0003	0.00265	CcSEcCtD
Etoricoxib—Anorexia—Fluorouracil—head and neck cancer	0.0003	0.00265	CcSEcCtD
Etoricoxib—Diarrhoea—Hydroxyurea—head and neck cancer	0.000299	0.00264	CcSEcCtD
Etoricoxib—Eye disorder—Docetaxel—head and neck cancer	0.000299	0.00264	CcSEcCtD
Etoricoxib—Cardiac disorder—Docetaxel—head and neck cancer	0.000297	0.00262	CcSEcCtD
Etoricoxib—Flushing—Docetaxel—head and neck cancer	0.000297	0.00262	CcSEcCtD
Etoricoxib—Angiopathy—Docetaxel—head and neck cancer	0.00029	0.00256	CcSEcCtD
Etoricoxib—Dizziness—Hydroxyurea—head and neck cancer	0.000289	0.00255	CcSEcCtD
Etoricoxib—Immune system disorder—Docetaxel—head and neck cancer	0.000289	0.00255	CcSEcCtD
Etoricoxib—Mediastinal disorder—Docetaxel—head and neck cancer	0.000288	0.00254	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000287	0.00253	CcSEcCtD
Etoricoxib—Arrhythmia—Docetaxel—head and neck cancer	0.000285	0.00252	CcSEcCtD
Etoricoxib—Nausea—Vinblastine—head and neck cancer	0.000285	0.00251	CcSEcCtD
Etoricoxib—Insomnia—Fluorouracil—head and neck cancer	0.000284	0.00251	CcSEcCtD
Etoricoxib—Alopecia—Docetaxel—head and neck cancer	0.000282	0.00249	CcSEcCtD
Etoricoxib—Dyspnoea—Fluorouracil—head and neck cancer	0.00028	0.00248	CcSEcCtD
Etoricoxib—Mental disorder—Docetaxel—head and neck cancer	0.00028	0.00247	CcSEcCtD
Etoricoxib—Somnolence—Fluorouracil—head and neck cancer	0.00028	0.00247	CcSEcCtD
Etoricoxib—Erythema—Docetaxel—head and neck cancer	0.000278	0.00246	CcSEcCtD
Etoricoxib—Malnutrition—Docetaxel—head and neck cancer	0.000278	0.00246	CcSEcCtD
Etoricoxib—Vomiting—Hydroxyurea—head and neck cancer	0.000278	0.00245	CcSEcCtD
Etoricoxib—Dyspepsia—Fluorouracil—head and neck cancer	0.000277	0.00245	CcSEcCtD
Etoricoxib—Rash—Hydroxyurea—head and neck cancer	0.000276	0.00243	CcSEcCtD
Etoricoxib—Dermatitis—Hydroxyurea—head and neck cancer	0.000275	0.00243	CcSEcCtD
Etoricoxib—Headache—Hydroxyurea—head and neck cancer	0.000274	0.00242	CcSEcCtD
Etoricoxib—Decreased appetite—Fluorouracil—head and neck cancer	0.000273	0.00242	CcSEcCtD
Etoricoxib—Dysgeusia—Docetaxel—head and neck cancer	0.000272	0.00241	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000272	0.0024	CcSEcCtD
Etoricoxib—Pain—Fluorouracil—head and neck cancer	0.000269	0.00238	CcSEcCtD
Etoricoxib—Muscle spasms—Docetaxel—head and neck cancer	0.000267	0.00236	CcSEcCtD
Etoricoxib—Nausea—Hydroxyurea—head and neck cancer	0.00026	0.00229	CcSEcCtD
Etoricoxib—Feeling abnormal—Fluorouracil—head and neck cancer	0.000259	0.00229	CcSEcCtD
Etoricoxib—Anaemia—Docetaxel—head and neck cancer	0.000257	0.00227	CcSEcCtD
Etoricoxib—Urticaria—Fluorouracil—head and neck cancer	0.00025	0.00221	CcSEcCtD
Etoricoxib—Palpitations—Docetaxel—head and neck cancer	0.000246	0.00217	CcSEcCtD
Etoricoxib—Cough—Docetaxel—head and neck cancer	0.000243	0.00214	CcSEcCtD
Etoricoxib—Hypertension—Docetaxel—head and neck cancer	0.00024	0.00212	CcSEcCtD
Etoricoxib—Chest pain—Docetaxel—head and neck cancer	0.000237	0.00209	CcSEcCtD
Etoricoxib—Arthralgia—Docetaxel—head and neck cancer	0.000237	0.00209	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000235	0.00208	CcSEcCtD
Etoricoxib—Hypersensitivity—Fluorouracil—head and neck cancer	0.000232	0.00205	CcSEcCtD
Etoricoxib—Dry mouth—Docetaxel—head and neck cancer	0.000232	0.00205	CcSEcCtD
Etoricoxib—Confusional state—Docetaxel—head and neck cancer	0.000229	0.00202	CcSEcCtD
Etoricoxib—Anaphylactic shock—Docetaxel—head and neck cancer	0.000227	0.00201	CcSEcCtD
Etoricoxib—Oedema—Docetaxel—head and neck cancer	0.000227	0.00201	CcSEcCtD
Etoricoxib—Infection—Docetaxel—head and neck cancer	0.000226	0.00199	CcSEcCtD
Etoricoxib—Shock—Docetaxel—head and neck cancer	0.000223	0.00197	CcSEcCtD
Etoricoxib—Nervous system disorder—Docetaxel—head and neck cancer	0.000223	0.00197	CcSEcCtD
Etoricoxib—Pruritus—Fluorouracil—head and neck cancer	0.000223	0.00197	CcSEcCtD
Etoricoxib—Thrombocytopenia—Docetaxel—head and neck cancer	0.000222	0.00196	CcSEcCtD
Etoricoxib—Skin disorder—Docetaxel—head and neck cancer	0.000221	0.00195	CcSEcCtD
Etoricoxib—Anorexia—Docetaxel—head and neck cancer	0.000216	0.00191	CcSEcCtD
Etoricoxib—Diarrhoea—Fluorouracil—head and neck cancer	0.000215	0.0019	CcSEcCtD
Etoricoxib—Dizziness—Fluorouracil—head and neck cancer	0.000208	0.00184	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000207	0.00183	CcSEcCtD
Etoricoxib—Insomnia—Docetaxel—head and neck cancer	0.000205	0.00181	CcSEcCtD
Etoricoxib—MAPK14—hair follicle—head and neck cancer	0.000204	0.155	CbGeAlD
Etoricoxib—Dyspnoea—Docetaxel—head and neck cancer	0.000202	0.00179	CcSEcCtD
Etoricoxib—Somnolence—Docetaxel—head and neck cancer	0.000202	0.00178	CcSEcCtD
Etoricoxib—Vomiting—Fluorouracil—head and neck cancer	0.0002	0.00177	CcSEcCtD
Etoricoxib—Dyspepsia—Docetaxel—head and neck cancer	0.0002	0.00177	CcSEcCtD
Etoricoxib—Rash—Fluorouracil—head and neck cancer	0.000198	0.00175	CcSEcCtD
Etoricoxib—Dermatitis—Fluorouracil—head and neck cancer	0.000198	0.00175	CcSEcCtD
Etoricoxib—Decreased appetite—Docetaxel—head and neck cancer	0.000197	0.00174	CcSEcCtD
Etoricoxib—Headache—Fluorouracil—head and neck cancer	0.000197	0.00174	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000196	0.00173	CcSEcCtD
Etoricoxib—Fatigue—Docetaxel—head and neck cancer	0.000196	0.00173	CcSEcCtD
Etoricoxib—Pain—Docetaxel—head and neck cancer	0.000194	0.00171	CcSEcCtD
Etoricoxib—Constipation—Docetaxel—head and neck cancer	0.000194	0.00171	CcSEcCtD
Etoricoxib—Feeling abnormal—Docetaxel—head and neck cancer	0.000187	0.00165	CcSEcCtD
Etoricoxib—Nausea—Fluorouracil—head and neck cancer	0.000187	0.00165	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000186	0.00164	CcSEcCtD
Etoricoxib—Abdominal pain—Docetaxel—head and neck cancer	0.000179	0.00159	CcSEcCtD
Etoricoxib—Hypersensitivity—Docetaxel—head and neck cancer	0.000167	0.00148	CcSEcCtD
Etoricoxib—Asthenia—Docetaxel—head and neck cancer	0.000163	0.00144	CcSEcCtD
Etoricoxib—Pruritus—Docetaxel—head and neck cancer	0.000161	0.00142	CcSEcCtD
Etoricoxib—MAPK14—mouth—head and neck cancer	0.00016	0.122	CbGeAlD
Etoricoxib—Diarrhoea—Docetaxel—head and neck cancer	0.000155	0.00137	CcSEcCtD
Etoricoxib—Dizziness—Docetaxel—head and neck cancer	0.00015	0.00133	CcSEcCtD
Etoricoxib—Vomiting—Docetaxel—head and neck cancer	0.000144	0.00127	CcSEcCtD
Etoricoxib—Rash—Docetaxel—head and neck cancer	0.000143	0.00126	CcSEcCtD
Etoricoxib—Dermatitis—Docetaxel—head and neck cancer	0.000143	0.00126	CcSEcCtD
Etoricoxib—Headache—Docetaxel—head and neck cancer	0.000142	0.00126	CcSEcCtD
Etoricoxib—MAPK14—neck—head and neck cancer	0.000137	0.104	CbGeAlD
Etoricoxib—Nausea—Docetaxel—head and neck cancer	0.000135	0.00119	CcSEcCtD
Etoricoxib—PTGS2—cartilage tissue—head and neck cancer	0.000113	0.0864	CbGeAlD
Etoricoxib—MAPK14—connective tissue—head and neck cancer	9.81e-05	0.0748	CbGeAlD
Etoricoxib—MAPK14—epithelium—head and neck cancer	9.32e-05	0.071	CbGeAlD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—head and neck cancer	8.56e-05	0.000588	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.54e-05	0.000586	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	8.5e-05	0.000584	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	8.43e-05	0.000579	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	8.38e-05	0.000576	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	8.31e-05	0.000571	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—MAPK3—head and neck cancer	8.29e-05	0.000569	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—AKT1—head and neck cancer	8.22e-05	0.000564	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—UROD—head and neck cancer	8.13e-05	0.000558	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	8.12e-05	0.000558	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	8e-05	0.000549	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—MAPK1—head and neck cancer	7.89e-05	0.000542	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—YAP1—head and neck cancer	7.79e-05	0.000535	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—HRAS—head and neck cancer	7.77e-05	0.000534	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.72e-05	0.00053	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—PIK3CA—head and neck cancer	7.72e-05	0.00053	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.72e-05	0.00053	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	7.64e-05	0.000525	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	7.64e-05	0.000525	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	7.64e-05	0.000524	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	7.62e-05	0.000524	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	7.6e-05	0.000522	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	7.49e-05	0.000515	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—UROD—head and neck cancer	7.48e-05	0.000514	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—UROD—head and neck cancer	7.41e-05	0.000509	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—AKT1—head and neck cancer	7.36e-05	0.000505	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.33e-05	0.000503	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	7.27e-05	0.000499	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	7.27e-05	0.000499	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	7.25e-05	0.000498	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	7.25e-05	0.000498	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	7.22e-05	0.000496	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	7.2e-05	0.000495	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—head and neck cancer	7.19e-05	0.000493	CbGpPWpGaD
Etoricoxib—MAPK14—lymphoid tissue—head and neck cancer	7.18e-05	0.0547	CbGeAlD
Etoricoxib—MAPK14—Signaling Pathways—KISS1—head and neck cancer	7.16e-05	0.000491	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—HRAS—head and neck cancer	7.15e-05	0.000491	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	7.1e-05	0.000488	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—head and neck cancer	7.07e-05	0.000486	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	7.06e-05	0.000485	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7e-05	0.000481	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PTEN—head and neck cancer	6.88e-05	0.000472	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	6.87e-05	0.000472	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—AKT1—head and neck cancer	6.86e-05	0.000471	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NOTCH1—head and neck cancer	6.86e-05	0.000471	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—BCL2L1—head and neck cancer	6.75e-05	0.000464	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.7e-05	0.00046	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—VEGFA—head and neck cancer	6.62e-05	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—head and neck cancer	6.62e-05	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—STAT3—head and neck cancer	6.56e-05	0.00045	CbGpPWpGaD
Etoricoxib—MAPK14—thyroid gland—head and neck cancer	6.52e-05	0.0497	CbGeAlD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.48e-05	0.000445	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—UROD—head and neck cancer	6.34e-05	0.000435	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	6.31e-05	0.000433	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—AKT1—head and neck cancer	6.31e-05	0.000433	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.31e-05	0.000433	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.29e-05	0.000432	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—MAPK3—head and neck cancer	6.27e-05	0.00043	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	6.25e-05	0.000429	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—STAT3—head and neck cancer	6.15e-05	0.000423	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	6.09e-05	0.000418	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.07e-05	0.000417	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—AKT1—head and neck cancer	6.07e-05	0.000417	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	5.96e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—MAPK1—head and neck cancer	5.96e-05	0.000409	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GRP—head and neck cancer	5.89e-05	0.000405	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MAPK3—head and neck cancer	5.88e-05	0.000404	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.86e-05	0.000403	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	5.84e-05	0.000401	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.78e-05	0.000397	CbGpPWpGaD
Etoricoxib—MAPK14—head—head and neck cancer	5.78e-05	0.0441	CbGeAlD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.75e-05	0.000395	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT6—head and neck cancer	5.72e-05	0.000393	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MAPK1—head and neck cancer	5.59e-05	0.000384	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—head and neck cancer	5.59e-05	0.000384	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.56e-05	0.000382	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CASP8—head and neck cancer	5.52e-05	0.000379	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.48e-05	0.000377	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.48e-05	0.000376	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.48e-05	0.000376	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.19e-05	0.000356	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	5.15e-05	0.000354	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—YAP1—head and neck cancer	5.06e-05	0.000348	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—head and neck cancer	5.01e-05	0.000344	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.94e-05	0.000339	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.93e-05	0.000339	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.93e-05	0.000339	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.91e-05	0.000338	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of mRNA—AKT1—head and neck cancer	4.91e-05	0.000337	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—UROD—head and neck cancer	4.89e-05	0.000336	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.89e-05	0.000336	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	4.87e-05	0.000335	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PIK3CA—head and neck cancer	4.85e-05	0.000333	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—BCL2—head and neck cancer	4.74e-05	0.000325	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NAT2—head and neck cancer	4.65e-05	0.000319	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—head and neck cancer	4.63e-05	0.000318	CbGpPWpGaD
Etoricoxib—PTGS2—mouth—head and neck cancer	4.61e-05	0.0351	CbGeAlD
Etoricoxib—MAPK14—Signaling by NGF—HRAS—head and neck cancer	4.49e-05	0.000308	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NAT2—head and neck cancer	4.38e-05	0.000301	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.28e-05	0.000294	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of RNA—AKT1—head and neck cancer	4.2e-05	0.000289	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.14e-05	0.000284	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DPYD—head and neck cancer	4.08e-05	0.00028	CbGpPWpGaD
Etoricoxib—MAPK14—lymph node—head and neck cancer	4.05e-05	0.0308	CbGeAlD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—head and neck cancer	4.01e-05	0.000276	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—STAT3—head and neck cancer	3.97e-05	0.000273	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—AKT1—head and neck cancer	3.96e-05	0.000272	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—head and neck cancer	3.94e-05	0.00027	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BCL2L1—head and neck cancer	3.93e-05	0.00027	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PTEN—head and neck cancer	3.92e-05	0.000269	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—YAP1—head and neck cancer	3.87e-05	0.000266	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DPYD—head and neck cancer	3.84e-05	0.000264	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MAPK3—head and neck cancer	3.8e-05	0.000261	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MAPK3—head and neck cancer	3.72e-05	0.000256	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—YAP1—head and neck cancer	3.64e-05	0.00025	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MAPK1—head and neck cancer	3.61e-05	0.000248	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—head and neck cancer	3.61e-05	0.000248	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.59e-05	0.000246	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.55e-05	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MAPK1—head and neck cancer	3.54e-05	0.000243	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NOTCH1—head and neck cancer	3.51e-05	0.000241	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.5e-05	0.00024	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NAT2—head and neck cancer	3.38e-05	0.000232	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK3—head and neck cancer	3.35e-05	0.00023	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.27e-05	0.000225	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.24e-05	0.000222	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CASP8—head and neck cancer	3.21e-05	0.000221	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK1—head and neck cancer	3.19e-05	0.000219	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—head and neck cancer	3.19e-05	0.000219	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDH1—head and neck cancer	3.18e-05	0.000218	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NAT2—head and neck cancer	3.11e-05	0.000213	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NAT2—head and neck cancer	3.08e-05	0.000211	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PIK3CA—head and neck cancer	3.07e-05	0.000211	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—head and neck cancer	2.97e-05	0.000204	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DPYD—head and neck cancer	2.96e-05	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—head and neck cancer	2.9e-05	0.000199	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—head and neck cancer	2.84e-05	0.000195	CbGpPWpGaD
Etoricoxib—PTGS2—connective tissue—head and neck cancer	2.82e-05	0.0215	CbGeAlD
Etoricoxib—CYP2C19—Metabolism—YAP1—head and neck cancer	2.81e-05	0.000193	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.79e-05	0.000192	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PIK3CA—head and neck cancer	2.77e-05	0.00019	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.77e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—BCL2—head and neck cancer	2.76e-05	0.000189	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DPYD—head and neck cancer	2.72e-05	0.000187	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DPYD—head and neck cancer	2.7e-05	0.000185	CbGpPWpGaD
Etoricoxib—PTGS2—epithelium—head and neck cancer	2.68e-05	0.0204	CbGeAlD
Etoricoxib—CYP1A2—Metabolism—NAT2—head and neck cancer	2.63e-05	0.000181	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—YAP1—head and neck cancer	2.58e-05	0.000177	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—YAP1—head and neck cancer	2.56e-05	0.000176	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—head and neck cancer	2.56e-05	0.000176	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—head and neck cancer	2.56e-05	0.000176	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.53e-05	0.000174	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—head and neck cancer	2.51e-05	0.000172	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—head and neck cancer	2.43e-05	0.000167	CbGpPWpGaD
Etoricoxib—PTGS2—trachea—head and neck cancer	2.37e-05	0.0181	CbGeAlD
Etoricoxib—PTGS2—Metabolism—TYMS—head and neck cancer	2.32e-05	0.00016	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DPYD—head and neck cancer	2.31e-05	0.000158	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTM1—head and neck cancer	2.3e-05	0.000158	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—head and neck cancer	2.29e-05	0.000157	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOTCH1—head and neck cancer	2.28e-05	0.000157	CbGpPWpGaD
Etoricoxib—CYP1A2—thyroid gland—head and neck cancer	2.26e-05	0.0172	CbGeAlD
Etoricoxib—MAPK14—Innate Immune System—AKT1—head and neck cancer	2.26e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2E1—lymphoid tissue—head and neck cancer	2.24e-05	0.0171	CbGeAlD
Etoricoxib—PTGS2—Metabolism—GPX1—head and neck cancer	2.2e-05	0.000151	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—YAP1—head and neck cancer	2.19e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TYMS—head and neck cancer	2.19e-05	0.00015	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.18e-05	0.000149	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTM1—head and neck cancer	2.16e-05	0.000148	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.11e-05	0.000145	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOTCH1—head and neck cancer	2.08e-05	0.000143	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GPX1—head and neck cancer	2.07e-05	0.000142	CbGpPWpGaD
Etoricoxib—PTGS2—lymphoid tissue—head and neck cancer	2.06e-05	0.0157	CbGeAlD
Etoricoxib—CYP2E1—Metabolism—CYP1A1—head and neck cancer	2.05e-05	0.000141	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—STAT3—head and neck cancer	2.04e-05	0.00014	CbGpPWpGaD
Etoricoxib—CYP2E1—thyroid gland—head and neck cancer	2.04e-05	0.0155	CbGeAlD
Etoricoxib—CYP3A4—Metabolism—NAT2—head and neck cancer	2.03e-05	0.000139	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK3—head and neck cancer	1.95e-05	0.000134	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MAPK3—head and neck cancer	1.94e-05	0.000133	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.92e-05	0.000132	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK1—head and neck cancer	1.86e-05	0.000128	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—head and neck cancer	1.86e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.84e-05	0.000126	CbGpPWpGaD
Etoricoxib—CYP2E1—head—head and neck cancer	1.81e-05	0.0138	CbGeAlD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.79e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DPYD—head and neck cancer	1.78e-05	0.000122	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—YAP1—head and neck cancer	1.69e-05	0.000116	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TYMS—head and neck cancer	1.69e-05	0.000116	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.68e-05	0.000115	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.67e-05	0.000115	CbGpPWpGaD
Etoricoxib—PTGS2—head—head and neck cancer	1.66e-05	0.0127	CbGeAlD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.64e-05	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—head and neck cancer	1.61e-05	0.000111	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—head and neck cancer	1.6e-05	0.00011	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.58e-05	0.000109	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—head and neck cancer	1.57e-05	0.000108	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TYMS—head and neck cancer	1.55e-05	0.000107	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TYMS—head and neck cancer	1.54e-05	0.000106	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.53e-05	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—head and neck cancer	1.53e-05	0.000105	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.52e-05	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—head and neck cancer	1.49e-05	0.000102	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—head and neck cancer	1.48e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—head and neck cancer	1.47e-05	0.000101	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—head and neck cancer	1.46e-05	0.0001	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.45e-05	9.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.44e-05	9.9e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.43e-05	9.85e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—head—head and neck cancer	1.43e-05	0.0109	CbGeAlD
Etoricoxib—PTGS2—Disease—PTEN—head and neck cancer	1.35e-05	9.26e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—head and neck cancer	1.33e-05	9.16e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—head and neck cancer	1.32e-05	9.07e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—head and neck cancer	1.32e-05	9.04e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMS—head and neck cancer	1.31e-05	9.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—head and neck cancer	1.31e-05	8.99e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.3e-05	8.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.3e-05	8.92e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK3—head and neck cancer	1.26e-05	8.67e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—head and neck cancer	1.24e-05	8.54e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.23e-05	8.46e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—head and neck cancer	1.22e-05	8.37e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—head and neck cancer	1.21e-05	8.28e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK1—head and neck cancer	1.2e-05	8.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—head and neck cancer	1.2e-05	8.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.18e-05	8.13e-05	CbGpPWpGaD
Etoricoxib—PTGS2—lymph node—head and neck cancer	1.16e-05	0.00887	CbGeAlD
Etoricoxib—PTGS2—Disease—MAPK3—head and neck cancer	1.15e-05	7.91e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—head and neck cancer	1.13e-05	7.75e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK1—head and neck cancer	1.1e-05	7.53e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—head and neck cancer	1.1e-05	7.52e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—head and neck cancer	1.06e-05	7.3e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—head and neck cancer	1.04e-05	7.16e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMS—head and neck cancer	1.01e-05	6.97e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.01e-05	6.95e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—head and neck cancer	1.01e-05	6.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—head and neck cancer	1e-05	6.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—head and neck cancer	9.64e-06	6.62e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—head and neck cancer	9.6e-06	6.59e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—head and neck cancer	9.51e-06	6.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.51e-06	6.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.4e-06	6.46e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—head and neck cancer	8.8e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—head and neck cancer	8.65e-06	5.94e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.57e-06	5.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—head and neck cancer	8.51e-06	5.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—head and neck cancer	8.2e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—head and neck cancer	7.96e-06	5.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—head and neck cancer	7.77e-06	5.33e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—head and neck cancer	7.54e-06	5.18e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—head and neck cancer	7.5e-06	5.15e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—head and neck cancer	7.48e-06	5.13e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—head and neck cancer	7.32e-06	5.03e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—head and neck cancer	6.51e-06	4.47e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—head and neck cancer	6.39e-06	4.39e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—head and neck cancer	6.12e-06	4.21e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.78e-06	3.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.65e-06	3.88e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.32e-06	3.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.27e-06	3.62e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—head and neck cancer	4.93e-06	3.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—head and neck cancer	4.72e-06	3.24e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.51e-06	3.09e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—head and neck cancer	4.35e-06	2.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—head and neck cancer	4.31e-06	2.96e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—head and neck cancer	3.68e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.48e-06	2.39e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—head and neck cancer	2.84e-06	1.95e-05	CbGpPWpGaD
